chronic-disease
(5)
Matthew Loper
Matthew Loper is the co-founder and CEO of Wellth, a Los Angeles digital-health company that pays people small cash rewards for sticking to their care plans. A biological engineer from MIT turned healthcare banker and investor, he built Wellth around behavioral economics rather than technology - the idea that immediate, tangible incentives change what people actually do about their chronic conditions. Under his leadership Wellth has raised more than $73 million, including an oversubscribed $36 million Series C in 2025, and reports steep drops in hospital and emergency-room use among the high-need Medicare and Medicaid populations it serves.
Glen Tullman
Glen Tullman is a serial health-tech entrepreneur and CEO of Transcarent, the consumer-directed health and care platform he founded in 2021. Over three decades he turned Allscripts into the dominant electronic health records provider, founded Livongo Health and sold it to Teladoc for $18.5 billion - the largest consumer digital health deal in history - and co-founded 7wireVentures, one of the top-returning venture funds in Illinois. Now leading Transcarent's $621M acquisition of Accolade and pushing AI-powered 'WayFinding' tools into employee benefits, Tullman is also a Giving Pledge signatory who has committed most of his estimated $1 billion fortune to healthcare and education.
Kurt Knight
Kurt Knight is the CEO of Foodsmart, the largest digital food-as-medicine platform in the United States, appointed in March 2025 after 13 years at Amwell where he rose to COO and helped scale virtual care nationally. With an MBA from Harvard, an MPH from Columbia, and field experience everywhere from UNICEF to the Gates Foundation to the Boston Consulting Group, Knight brings an unusually wide lens to the intersection of food, nutrition, and healthcare delivery.
Margo Georgiadis
Margo Georgiadis is CEO-Partner at Flagship Pioneering and co-founder & CEO of Montai Therapeutics, a biotech company using AI to discover drugs from natural compounds humans have consumed for centuries. A Harvard double-alumna (Phi Beta Kappa undergrad, Baker Scholar MBA), she has reinvented herself across industries - from McKinsey partner to Google Americas President, Mattel CEO, Ancestry.com CEO (overseeing its $5B sale to Blackstone), and now biotech pioneer building a platform that turns ancient botanicals and foods into precision medicines for chronic disease.
Julia Hu
Julia Hu is the co-founder and CEO of Lark Health, an AI-powered virtual care platform managing over 30 million contracted lives. Born in Los Angeles to first-generation Chinese immigrants and raised largely by her father, Hu spent her childhood navigating an undiagnosed chronic condition that would ultimately reshape how she saw healthcare. She dropped out of MIT Sloan mid-MBA to build what is now one of the largest CDC-recognized diabetes prevention program providers in the country, having raised over $257 million and earned recognition from Forbes, Inc., and the UCSF Health Awards Hall of Fame.